You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

coxsackievirus type a21

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma Trial in United States (CAVATAK, Ipilimumab)

Completed
  • Melanoma
  • Duarte, California
  • +10 more
Jan 12, 2023

Stage IV Melanoma Trial in Brisbane (Coxsackievirus A21)

Completed
  • Stage IV Melanoma
  • Coxsackievirus A21
  • Brisbane, Queensland, Australia
    Princess Alexandra Hospital
Jun 26, 2019

Type2diabetes, Endothelial Dysfunction Trial in Malmö (C21)

Recruiting
  • Type2diabetes
  • Endothelial Dysfunction
  • Malmö, Sweden
    Skånes universitetssjukhus
Apr 25, 2023

Diabetes, Type 2 Trial in Czechia, Thailand (Insulin Icodec, Semaglutide)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Broumov, Czechia
  • +7 more
Apr 3, 2023

Melanoma Trial in Worldwide (Pembrolizumab, Vibostolimab, V937)

Recruiting
  • Melanoma
  • Pembrolizumab
  • +5 more
  • Los Angeles, California
  • +28 more
Jan 25, 2023

Teenagers and Hereditary Angioedema Type I or Type II Who Use

Completed
  • Hereditary Angioedema (HAE)
    • Graz, Austria
    • +19 more
    Jan 12, 2023

    COVID-19 Trial (1 Nebulized inhalation for booster groups, 2 Nebulized inhalation for booster groups, 3 Nebulized inhalation for

    Recruiting
    • COVID-19
    • 1 Nebulized inhalation for booster groups
    • +23 more
    • Xiangxi, Hunan, China
      CDC of of Luxi County, Xiangxi Tujia and Miao Autonomous Prefect
    Oct 24, 2022

    Empagliflozin, Other SGLT-2 Inhibitors, or DPP-4 Inhibitors in

    Completed
    • Diabetes Mellitus, Type 2
    • Subjects treated with Empagliflozin or any Sodium-glucose cotransporter-2 (SGLT-2) inhibitor
    • Subjects treated with Dipeptidyl peptidase-4 (DPP-4) inhibitor
    • Gentofte, Denmark
    • +12 more
    Jan 18, 2022

    Herpes Simplex Type 2 Trial in Portland, Houston, Seattle (HerpV and QS-21, Placebo)

    Completed
    Has Results
    • Herpes Simplex Type 2
    • HerpV and QS-21
    • Placebo
    • Portland, Oregon
    • +4 more
    Jun 22, 2021

    Malignant Melanoma Trial in Newcastle (Coxsackievirus A21)

    Completed
    • Malignant Melanoma
    • Coxsackievirus A21
    • Newcastle, New South Wales, Australia
      Melanoma Unit, Mater Misericordiae Hospital
    Jun 26, 2019

    Type 2 Diabetes Trial in Argentina, China, Mexico (LY900014, Insulin Lispro, Insulin Glargine)

    Completed
    Has Results
    • Type 2 Diabetes Mellitus
    • Buenos Aires, Ar-c, Argentina
    • +40 more
    Jan 11, 2022

    Type 2 Diabetes Trial in Aberdeen (Bilberry capsule first, then control cap, Control capsule first then bilberry cap)

    Completed
    Has Results
    • Type 2 Diabetes
    • Bilberry capsule first, then control cap
    • Control capsule first then bilberry cap
    • Aberdeen, United Kingdom
      University of Aberdeen Rowett Institute of Nutrition and Health
    Feb 18, 2021

    Narcolepsy Type 1 (NT1), Narcolepsy Type 2 (NT2) Trial in Worldwide (TAK-994, Placebo)

    Terminated
    • Narcolepsy Type 1 (NT1)
    • Narcolepsy Type 2 (NT2)
    • Alabaster, Alabama
    • +77 more
    Oct 5, 2022

    Melanoma Trial in Santa Monica, New Brunswick, Canton (CAVATAK, Pembrolizumab)

    Completed
    • Melanoma
    • Santa Monica, California
    • +2 more
    Jan 14, 2020

    Rare Disorders, Undiagnosed Disorders, Disorders of Unknown Prevalence Trial in Sioux Falls, Sydney

    Recruiting
    • Rare Disorders
    • +309 more
      • Sioux Falls, South Dakota
      • +1 more
      Jun 20, 2022

      Diabetes, Type 2 Trial in Aberdeen (Tinned mackerel fish)

      Recruiting
      • Diabetes Mellitus, Type 2
      • Tinned mackerel fish
      • Aberdeen, United Kingdom
        University of Aberdeen Rowett Institute of Nutrition and Health
      Feb 18, 2021

      Familial Chylomicronemia Syndrome Trial in Canada, Sweden, United States (Olezarsen)

      Recruiting
      • Familial Chylomicronemia Syndrome
      • Huntington Beach, California
      • +10 more
      Aug 4, 2022

      Recent-Onset Type 1 Diabetes Extension Study Evaluating

      Enrolling by invitation
      • Type 1 Diabetes Mellitus
      • Teplizumab
      • Placebo
      • San Diego, California
      • +41 more
      Jan 31, 2023

      Diabetes, Type 1 Trial in Cairo (probiotics)

      Recruiting
      • Diabetes Mellitus, Type 1
      • probiotics
      • Cairo, Ramses, Egypt
      • +1 more
      Oct 2, 2020

      Head Neck Cancer Trial in Darlinghurst, Newcastle, Clayton (CVA21)

      Terminated
      • Head and Neck Cancer
      • CVA21
      • Darlinghurst, New South Wales, Australia
      • +2 more
      Jul 16, 2019

      Type 2 Diabetes, Renal Impairment Trial in Worldwide (Insulin glargine 300 U/mL, Insulin degludec 100 U/mL)

      Recruiting
      • Type 2 Diabetes Mellitus
      • Renal Impairment
      • Insulin glargine 300 U/mL
      • Insulin degludec 100 U/mL
      • Yuma, Arizona
      • +62 more
      Dec 14, 2022

      Sodium-glucose Cotransporter 2 Inhibitors and Risk of

      Completed
      • Type2 Diabetes
      • +5 more
      • Sodium-glucose cotransporter 2 (SGLT2) inhibitors
      • Dipeptidyl peptidase-4 (DPP-4) inhibitors
      • Montreal, Quebec, Canada
        Lady Davis Institute for Medical Research, Jewish General Hospit
      Oct 1, 2020

      HIV-I, Human Immunodeficiency Virus Type 1, Prophylaxis Trial in South Africa, Uganda, United States (Islatravir, Placebo to

      Active, not recruiting
      • HIV-I
      • +2 more
      • Birmingham, Alabama
      • +23 more
      Aug 15, 2022

      Type 2 Diabetes Trial in Worldwide (Bexagliflozin, Placebo for Bexagliflozin, Glimepiride)

      Completed
      Has Results
      • Type 2 Diabetes Mellitus
      • Birmingham, Alabama
      • +44 more
      May 25, 2021

      Diabetes, Type 2 Diabetes Trial in Worldwide (LY3209590, Insulin Degludec)

      Recruiting
      • Diabetes
      • Type 2 Diabetes
      • Escondido, California
      • +128 more
      Jan 18, 2023